Canada· CA-DIN-02463644
ACARIZAX
A hausstaubmilben product containing dermatophagoides farinae + dermatophagoides pteronyssinus, registered in Canada by ALK-ABELLO A/S. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Hausstaubmilben is registered in 11 of 19 countries.
Countries holding a registration under ATC V01AA03 (hausstaubmilben), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Hausstaubmilben · ATC V01AA03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DERMATOPHAGOIDES FARINAE + DERMATOPHAGOIDES PTERONYSSINUS
- Manufacturer
- ALK-ABELLO A/S
- Country
- Canada (CA)
- ATC code
- V01AA03
- ATC class
- Hausstaubmilben
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hausstaubmilben in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOdactraALK-Abello A S
- SwedenAcarizax 12 SQ-HDM Frystorkad sublingual tablettMedartuum AB
- NorwayAcarizaxALK-Abelló AS
- IrelandACARIZAX 12 SQ-HDM sublingual lyophilisateALK-Abello A/S
- GermanyAcarizaxAlk-Abello A/S
- SpainACARIZAX 12 SQ-HDM LIOFILIZADO SUBLINGUALAlk-Abello A/S
- FinlandAcarizaxALK-Abello A/S
- IcelandSoluprick SQ (House Dust Mites)ALK-Abelló A/S
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Acarizax, Actair
- Belgium · Acarizax, Orylmyte
- Bulgaria · Актаир, Алиостал Прик, Алергенен Екстракт От Микрокърлежи
- Czechia · Acarizax, Actair
- Germany · Acarizax, Aitaro
- Denmark · Acarizax, Aitmyte
- Spain · Acarizax, Actair
- Finland · Acarizax
- France · Acarizax, Dusetlis
- United Kingdom (Northern Ireland) · Acarizax, Actair
- Croatia · Acarizax, Orylmyte
- Hungary · Acarizax, Staloral
- Ireland · Acarizax, Actair
- Italy · Accarizax, Orylmyte
- Luxembourg · Acarizax, Orylmyte
- Netherlands · Acarizax, Actair
- Norway · Acarizax, Aitmyte
- Poland · Acarizax, Actair
- Portugal · Actair
- Romania · Acarizax, Actair
- Sweden · Acarizax, Aitmyte
- Slovenia · Acarizax, Actair
- Slovakia · Acarizax, Actair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/05aad881-2f79-490c-9cd6-e6cc1d0a5981 GET /v1/drugs/05aad881-2f79-490c-9cd6-e6cc1d0a5981?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02463644",
"form": "TABLET",
"class": "Human",
"routes": [
"SUBLINGUAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V01AA03",
"schedule": [
"Schedule D",
"Prescription"
],
"drug_code": "95174",
"strengths": [
"6 UNIT"
],
"ahfs_class": null,
"substances": [
"DERMATOPHAGOIDES FARINAE",
"DERMATOPHAGOIDES PTERONYSSINUS"
],
"product_categorization": null
}See everything about hausstaubmilben.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.